The skin autofluorescence may help to select patients with Type 2 diabetes candidates for screening to revascularization procedures

Chen et al. recently related the skin autofluorescence (SAF) of Advanced Glycation End-products to subclinical cardiovascular disease in the 3001 participants from the general population (Rotterdam study), with a particularly close relationship for the 413 subjects with diabetes. Because conventiona...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cardiovascular diabetology Jg. 23; H. 1; S. 32 - 4
Hauptverfasser:	Alkhami, Fadi, Borderie, Gauthier, Foussard, Ninon, Larroumet, Alice, Blanco, Laurence, Barbet-Massin, Marie-Amélie, Ferriere, Amandine, Ducos, Claire, Mohammedi, Kamel, Fawaz, Sami, Couffinhal, Thierry, Rigalleau, Vincent
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	London BioMed Central 13.01.2024 Springer Nature B.V BMC
Schlagworte:	Advanced glycation end-products Advanced glycosylation end products Angiology Arteries Atherosclerosis Cardiology Cardiovascular disease Cardiovascular diseases Carotid arteries Clinical trials Cohort analysis Comment Coronary vessels Diabetes Diabetes mellitus (non-insulin dependent) Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - diagnosis Foot diseases Glycation End Products, Advanced Health risks Human health and pathology Humans Ischemia Leg ulcers Life Sciences Medical prognosis Medicine Medicine & Public Health Mortality Myocardial ischemia Population studies Revascularization Risk Factors Skin Skin autofluorescence Smoking Type 2 diabetes Vein & artery diseases Skin autofluorescence Type 2 diabetes Advanced glycation end-products Revascularization Advanced Humans Risk Factors Type 2 Skin Diabetes Mellitus Glycation End Products Smoking
ISSN:	1475-2840, 1475-2840
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!